PHT Home > 2010 U.S. User Group Meeting: Agenda
Program Agenda
| Tuesday, March 16, 2010 | |
|---|---|
| Attendees arrive all day | |
| 2:00 pm - 5:00 pm | Meeting Registration |
| 6:00 pm | Welcome Reception and Dinner |
| Wednesday, March 17, 2010 | |
| 7:30 am | Breakfast |
| 8:30 am | Welcome and Opening Remarks
VP of Marketing and Product Management PHT Corporation |
| 9:15 am | Industry Overview
President and CEO PHT Corporation |
| 9:45 am | New/Expert Users Breakout
General Manager of Europe PHT Corporation
Principal Oxford Outcomes |
| 10:30 am | Break |
| 10:45 am | Site-Based Subject Data: Using an ePRO Tablet
President and Founder DSP Clinical |
| 11:15 am | PHT Spotlight and Product Update
Product Manager PHT Corporation |
| 11:45 am | Realizing the Promise of ePRO and Future Applications
Founder and Chief Scientific and Quality Officer PHT Corporation |
| 12:15 pm | Lunch - Keynote Presentation: Globalization and Socialization of Clinical Trials
Managing Editor Applied Clinical Trials Magazine |
| 1:15 pm | The Site Perspective
Site Coordinator The Houston Sleep Center |
| 1:45 pm | Breakout Session I |
| 3:00 pm | Depart for Networking Activity and Dinner |
| Thursday, March 18, 2010 | |
| 7:30 am | Breakfast |
| 8:30 am | Using ePRO and EDC
Director of Data Management Jazz Pharmaceuticals |
| 9:00 am | Breakout Session II |
| 10:15 am | Break |
| 10:30 am | Project Management: Key Components for a Successful ePRO Study
Vice President of Client Services PHT Corporation |
| 11:00 am | Selection Criteria for PRO and ePRO Trials
Clinical Operations Manager Celgene Corporation |
| 11:30 am | Breakout Session III |
| 12:30 pm | Final Remarks
VP of Marketing and Product Management PHT Corporation |
| 1:00 pm | Lunch |
| 2:00 pm | U.S. 2010 User Group Meeting Concludes |
Breakout Session Topics
The PHT PRO and ePRO Conference includes a series of interactive breakout sessions where attendees will actively participate in discussions on specialty topics. The topics for the breakout sessions include:
- Managing the PRO Dossier
- 6 successful methods used to collect PRO data, and their mixed use within trials
- FDA and EMEA Guidance Regulations, and their implications
- Leveraging eClinical Integrations
- Regulatory Objectives for ePRO Archives
- The ROI of ePRO
- Training Programs for Users, Sites and CROs
- Review of the Successful DCF Process

